[The stream is slated to start at 3 p.m. ET. Please refresh the page if you do not see a player above at that time.]
President Donald Trump is expected to sign three executive orders on Friday targeting the pharmaceutical industry with the goal of reducing drug prices.
It is unclear what will be included in the three orders.
But one of the orders could allow states and pharmacies to import Canadian drugs, The Washington Post reported, a proposal the White House submitted last year that received strong criticism from pharmaceutical companies.
Another would relate the prices of some drugs to the lowest prices paid in other countries, a proposal considered as an international price index, according to the Post. This proposal would try to ensure that the United States does not pay more for drugs than other countries.
And while Trump is expected to sign these executive orders, the regulatory process itself could take months and bleed until November, when voters choose whether to elect Trump for a second term.
Prescription drug prices have long been a concern for many Americans, one that arises when Democrats and Republicans clash over the issue of health care. The Trump administration has spoken up and made moves to reverse the Affordable Care Act, a healthcare reform signed by former President Barack Obama.
Executive orders also come at a time when the administration is injecting billions of dollars into the pharmaceutical industry to eject a vaccine to treat the coronavirus.
The coronavirus outbreak has spread worldwide, with more than 15.3 million confirmed cases and more than 625,000 deaths, according to data from Johns Hopkins University. The United States has had more than 3.9 million cases and at least 143,466 deaths, according to the latest counts, more than any other country.
Subscribe to CNBC on YouTube.
